|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2010-7-26
|
|
pubmed:abstractText |
6-Mercaptopurine (6-MP) has been the backbone of maintenance chemotherapy for acute lymphoblastic leukemia (ALL), the response to 6-MP is highly variable, adverse events leading to discontinuation or dose-reduction (children intolerant) of 6-MP occur in many children with ALL. The aim of this study was to investigate the tolerability of 6-MP and to optimize thiopurine use.
|
|
pubmed:language |
chi
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0578-1310
|
|
pubmed:author |
pubmed-author:DuanYan-longYL,
pubmed-author:GuoHai-yingHY,
pubmed-author:JinLingL,
pubmed-author:MaXiao-liXL,
pubmed-author:TUIP CPC,
pubmed-author:WoodR WRW,
pubmed-author:WuMin-yuanMY,
pubmed-author:YangJingJ,
pubmed-author:ZhangDa-weiDW,
pubmed-author:ZhangLiL,
pubmed-author:ZhangRuiR,
pubmed-author:ZhangYong-hongYH,
pubmed-author:ZhuGuang-huaGH
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
48
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
289-92
|
|
pubmed:meshHeading |
pubmed-meshheading:20654019-6-Mercaptopurine,
pubmed-meshheading:20654019-Adolescent,
pubmed-meshheading:20654019-Antimetabolites, Antineoplastic,
pubmed-meshheading:20654019-Child,
pubmed-meshheading:20654019-Child, Preschool,
pubmed-meshheading:20654019-Drug Resistance, Neoplasm,
pubmed-meshheading:20654019-Female,
pubmed-meshheading:20654019-Humans,
pubmed-meshheading:20654019-Infant,
pubmed-meshheading:20654019-Male,
pubmed-meshheading:20654019-Precursor Cell Lymphoblastic Leukemia-Lymphoma,
pubmed-meshheading:20654019-Prospective Studies
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
[Tolerability of 6-mercaptopurine in children with acute lymphoblastic leukemia].
|
|
pubmed:affiliation |
Hematology Center, Beijing Children's Hospital, Capital Medical University, Beijing 100045, China.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
English Abstract
|
